Brand-name drug
Singulair price, strengths & recalls
Brand of montelukast (generic)
Pharmacies pay $276.82 for 30 tablets of Singulair 10 mg tablet this week, and from $276.82 to $278.22 across its 2 priced strengths and forms. The generic, montelukast, costs pharmacies from $1.30. It is in shortage (being discontinued). It has 14 recalls on record, none ongoing. Its official label last changed on June 25, 2025.
Being discontinuedBrand- Fair cash price
- $328.84
- Strengths
- 2
- Makers
- 1
- Updated
- Nov 11
Singulair price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 5 mg chewable tablet Brand | $9.27 | $278.22 / 30 tablets |
| 10 mg tablet Brand | $9.23 | $276.82 / 30 tablets |
Singulair vs generic montelukast
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
GenericMontelukast pricesSupply status: shortages & recalls
Shortages
- Singulair, Tablet, Chewable, 4 mg (NDC 78206-170-01)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 14 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Singulair
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR.SINGULAIR® (montelukast sodium) tablets, for oral use SINGULAIR® (montelukast sodium) chewable tablets, for oral use SINGULAIR® (montelukast sodium) oral granulesInitial U.S. Approval: 1998
WARNING: SERIOUS NEUROPSYCHIATRIC EVENTS
Serious neuropsychiatric (NP) events have been reported with the use of SINGULAIR. The types of events reported were highly variable, and included, but were not limited to, agitation, aggression, depression, sleep disturbances, suicidal thoughts and behavior (including suicide). The mechanisms underlying NP events associated with SINGULAIR use are currently not well understood [see Warnings and Precautions (5.1)].
Because of the risk of NP events, the benefits of SINGULAIR may not outweigh the risks in some patients, particularly when the symptoms of disease may be mild and adequately treated with alternative therapies. Reserve use of SINGULAIR for patients with allergic rhinitis who have an inadequate response or intolerance to alternative therapies [see Indications and Usage (1.3)]. In patients with asthma or exercise-induced bronchoconstriction, consider the benefits and risks before prescribing SINGULAIR.
Discuss the benefits and risks of SINGULAIR with patients and caregivers when prescribing SINGULAIR. Advise patients and/or caregivers to be alert for changes in behavior or new NP symptoms when taking SINGULAIR. If changes in behavior are observed, or if new NP symptoms or suicidal thoughts and/or behavior occur, advise patients to discontinue SINGULAIR and contact a healthcare provider immediately [see Warnings and Precautions (5.1)].
WARNING: SERIOUS NEUROPSYCHIATRIC EVENTS
See full prescribing information for complete boxed warning.
Serious neuropsychiatric events have been reported in patients taking SINGULAIR (5.1).
Discuss benefits and risks of SINGULAIR with patients and caregivers (5.1).
Monitor for neuropsychiatric symptoms in patients taking SINGULAIR (5.1).
Discontinue SINGULAIR immediately if neuropsychiatric symptoms occur (5.1).
Because the benefits of SINGULAIR may not outweigh the potential risk of neuropsychiatric symptoms in patients with allergic rhinitis, reserve use for patients who have an inadequate response or intolerance to alternative therapies (1.3, 5.1).
Recent major changes (as listed on the label)
Indications and Usage (1.3, 1.4) | 02/2021 |
Dosage and Administration (2.1, 2.2, 2.3, 2.4) | 02/2021 |
Warnings and Precautions (5.1, 5.6) | 02/2021 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA020829 · Organon
- First approved
- February 20, 1998 (28 years ago)
- Latest approved change
- February 22, 2021
- Approved label
- PDF, Feb 24, 2021
- Generic makers
- 23 approved generic applications on the market
Singulair questions
How much does singulair cost without insurance?
Pharmacies pay about $276.82 for 30 tablets of singulair 10 mg tablet ($9.23 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $328.84. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Singulair?
Yes: montelukast. Pharmacies pay from $1.30 for it. Compare montelukast prices.
Is singulair in shortage?
Yes. 1 product is listed as in shortage or being discontinued (being discontinued). See which ones.
Has singulair been recalled?
14 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the singulair label last change?
The official label was last updated on June 25, 2025 (version 5). See what changed.
Talk about singulair
No comments yet. Questions, tips, what worked for you - start the conversation.